Cargando…
A targeted methicillin-resistant Staphylococcus aureus (MRSA) control program did not affect total nosocomial Staphylococcus aureus (SA) bloodstream infections (BSI) despite reducing MRSA BSI
Autores principales: | Amri, B, Vasudevan, A, Li, J, Hsu, LY, Fisher, D, Tambyah, PA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239463/ http://dx.doi.org/10.1186/1753-6561-5-S6-O5 |
Ejemplares similares
-
Combination Vancomycin/Cefazolin (VAN/CFZ) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
por: Trinh, Trang D, et al.
Publicado: (2017) -
1596. Impact of Vancomycin Area Under Curve on Persistent Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
por: Alosaimy, Sara, et al.
Publicado: (2019) -
Lower Methicillin-Resistant Staphylococcus aureus (MRSA) Acquisition and Nosocomial Cultures While on Anti-MRSA Antibiotics?
por: Jones, Makoto, et al.
Publicado: (2015) -
Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)
por: Hooper, Candace Y, et al.
Publicado: (2012) -
Laser Treatment Increases the Antimicrobial Efficacy of Cyanobacterial Extracts against Staphylococcus
aureus (SA) and Methicillin-resistant
Staphylococcus aureus (MRSA)
por: Al Naim, Haifa M., et al.
Publicado: (2022)